Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study

Paul M. Zeltzer, James M. Boyett, Jonathan L. Finlay, A. Leland Albright, Lucy B. Rorke, Jerrold M. Milstein, Jeffrey C. Allen, Kenneth R. Stevens, Philip Stanley, Hao Li, Jeffrey H. Wisoff, J. Russell Geyer, Patsy McGuire-Cullen, James A. Stehbens, Susan B. Shurin, Roger J. Packer

Research output: Contribution to journalArticlepeer-review

562 Scopus citations

Fingerprint

Dive into the research topics of 'Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study'. Together they form a unique fingerprint.

Medicine & Life Sciences